Publications

Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin

​

The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development

​

Astrocytes, the rising stars of the glioblastoma microenvironment

​

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma

​

LMTK3 confers chemo-resistance in breast cancer

​

Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes

​

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma

​

Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling

​

Strategies in functional proteomics: Unveiling the pathways to precision oncology

​

Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention

​

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer

​

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation

​

LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5

​

Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor

​

The many-faced KSR1: a tumor suppressor in breast cancer

​

Reply: When does a human being die?

​

LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer

​

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics

​

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer

​

When does a human being die?

​

Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer

​

Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer

​

Targeting lemurs against cancer metastasis

​

The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁

​

KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

​

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma

​

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1

​

Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States

​

The dual function of KSR1: a pseudokinase and beyond

​

Cancer stem cells--therapeutic targeting or therapy?

​

The regulatory roles of phosphatases in cancer

​

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen

​

Claudin-1 as a promoter of EMT in hepatocellular carcinoma

​

LATS2 is a modulator of estrogen receptor alpha

​

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo

​

LMTK3 is implicated in endocrine resistance via multiple signaling pathways

​

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

​

The role of pseudokinases in cancer

​

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution

​

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome

​

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

​

The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy

​

Kinases as targets in the treatment of solid tumors

​

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response

​

CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions

​

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer

​

Bendamustine as a model for the activity of alkylating agents

​

Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo

​

Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2

​

Clinical significance of circulating tumor cells

​

Protein kinases as targets for cancer treatment

​

Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo

​

Targeting LMTK3 in ovarian cancer: A dual role in prognosis and therapy

​

A brain metastasis liquid biopsy: Where are we now?

​

The brain-specific kinase LMTK3 regulates neuronal excitability by decreasing KCC2-dependent neuronal Cl(-) extrusion

​

Management of glioblastoma in elderly patients: A review of the literature

​

MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency

​

Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

​

Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment

​

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

​

A revised nomenclature for the lemur family of protein kinases

​

A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data

​

Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma

​

The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications

​

Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment

​

Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer

​

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor

​

Design and reporting of phase III oncology trials with prospective biomarker validation

​

Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications

​

Effectiveness of X-ray micro-CT applications upon mafic and ultramafic ophiolitic rocks

​

PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling

​

Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas

​

Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment

​

Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients

​

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma

​

Tuneable synthetic reduced graphene oxide scaffolds elicit high levels of three-dimensional glioblastoma interconnectivity in vitro

​

Diving into the dark kinome: lessons learned from LMTK3

​

Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies

​

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers

​

The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier

​

The multifaceted role of lemur tyrosine kinase 3 in health and disease

​

Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer

​

Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth

​

Cancer gene therapy 2020: highlights from a challenging year

​

Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

​

Correction to: LMTK3 inhibition affects microtubule Stability

​

LMTK3 inhibition affects microtubule stability

​

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1)

​

Graphene-Induced Transdifferentiation of Cancer Stem Cells as a Therapeutic Strategy against Glioblastoma

​

The structure-function relationship of oncogenic LMTK3

​

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing

​

Langmuir Films of Layered Nanomaterials: Edge Interactions and Cell Culture Applications

​

Breaking through the glioblastoma micro-environment via extracellular vesicles

​

Three Method-Combination Protocol for Improving Purity of Extracellular Vesicles

​

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression

​

Cancer Gene Therapy: vision and strategy for the new decade

​

Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line

​

Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping

​

Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy

​

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?

​